Hypoglycemia Management in the Hospital—What Have We Learned from the COVID-19 Pandemic?
Room 356
Level 3, Ernest N. Morial Convention Center
Q&A with Ilias (Elias) Spanakis, MD
Associate Professor of Medicine,
University of Maryland, School of Medicine
What is your presentation about?
This presentation is about the use of CGM devices in the hospital setting, focusing on what we learned recently, following the COVID-19 declaration. I am going to present the different ways that CGM systems were used, alone or in conjunction with smart devices and how the CGM data can be utilized by either the nurses or the providers for treatment decisions. I am also going to present data about a recent multicenter study that we participated in and in which Dr. Umpierrez was the Principal Investigator.
What makes this topic important in 2022?
After the COVID-19 declaration and following the FDA “non-objection” to use CGM devices in the hospital, our knowledge of using CGM devices in the inpatient setting has increased significantly.
How did you become involved with this area of diabetes research or care?
I had always an interest in research for the hospital setting. It was however a challenging case of hypoglycemia in a hospitalized patient with T1DM that made me utilize CGM device-technology in the inpatient setting and start building my research career.
What are you most looking forward to at the 82nd Scientific Sessions?
I am particularly interested to hear of any updates related to diabetes and technology, in either the inpatient or the outpatient setting.
[sub-post-content]